Clinical Trial Details

SLV-154 Treatment of Metastatic Solid Tumors

Complete Title: A Phase 1 Dose-Escalation Study of SLV-154 in Subjects with Metastatic Solid Tumors
Trial Phase: I
Investigator: Rafael Santana-Davila

This is a Phase 1 dose-escalation study evaluating the safety, pharmacokinetics, pharmacodynamics, immunogenicity, and efficacy of SLV-154 across a range of dose levels when administered to subjects with metastatic solid tumors.

Keywords:
  • Breast Cancer; Cervical Cancer; Endometrial Cancer; Ovarian Cancer; Sarcoma; Thyroid Cancer; Lung Carcinoma, Non-Small-Cell (NSCLC); Carcinoma, Squamous Cell; Lung Carcinoma, Small-Cell; Urothelial Cancer
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Checklist icon

Join a Clinical Trial

Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.

Contact Us

If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.